Cite Filings / REPL / 0001104659-26-065261

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Replimune Group, Inc. Filed 2026-05-21 Acc 0001104659-26-065261

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-08-07 SCHEDULE 13G Statement of Beneficial Ownership
2026-05-21 SCHEDULE 13G Statement of Beneficial Ownership
2026-05-20 4 Chief Medical Officer sold 14,023 shares at $5.08 ($71,237)
2026-05-20 4 Chief Accounting Officer sold 7,894 shares at $5.08 ($40,102)
2026-05-20 4 Chief Commercial Officer sold 8,626 shares at $5.08 ($43,820)
2026-05-20 4 Director sold 17,657 shares at $5.08 ($89,698)
2026-05-12 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…